GLENMEDE TRUST CO NA - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 231 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$15,000
+7.1%
904
+4.1%
0.00%
Q2 2020$14,000
+16.7%
868
-18.8%
0.00%
Q1 2020$12,0000.0%1,0690.0%0.00%
Q4 2019$12,000
+20.0%
1,069
+48.7%
0.00%
Q3 2019$10,000
+66.7%
719
+26.8%
0.00%
Q2 2019$6,0000.0%5670.0%0.00%
Q1 2019$6,000
-14.3%
5670.0%0.00%
Q4 2018$7,000
-98.3%
567
-97.4%
0.00%
-100.0%
Q3 2017$414,00021,4620.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,372,001$98,287,0004.68%
TANAKA CAPITAL MANAGEMENT INC 79,574$934,0002.82%
Consonance Capital Management LP 3,747,453$43,995,0002.78%
S&T BANK/PA 613,740$7,205,0001.62%
AJ WEALTH STRATEGIES, LLC 595,834$6,995,0001.16%
Capital Impact Advisors, LLC 193,694$2,522,0001.12%
TEALWOOD ASSET MANAGEMENT INC 154,615$1,815,0000.77%
AMI ASSET MANAGEMENT CORP 722,932$8,487,0000.63%
Birchview Capital, LP 50,000$587,0000.37%
FEDERATED HERMES, INC. 11,176,281$131,210,0000.32%
View complete list of CORCEPT THERAPEUTICS INC shareholders